Affinity Asset Advisors’s BELLUS Health Inc. BLU Stock Holding History

Affinity Asset Advisors’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-881,329	Closed	-$6.35M	–	95
2023 Q1	$6.35M	Buy	881,329 +307,651	+54%	+$2.39M	2.09%	17
2022 Q4	$4.72M	Buy	573,678 +100,081	+21%	+$933K	1.85%	21
2022 Q3	$5M	Sell	473,597 -19,681	-4%	-$209K	1.4%	19
2022 Q2	$4.56M	Sell	493,278 -106,722	-18%	-$873K	1.92%	19
2022 Q1	$4.13M	Buy	600,000 +100,000	+20%	+$644K	0.66%	27
2021 Q4	$4.03M	Sell	500,000 -32,030	-6%	-$213K	1.46%	27
2021 Q3	$3.27M	Buy	532,030 +232,030	+77%	+$880K	0.83%	30
2021 Q2	$933K	Hold	300,000	–	–	0.33%	56
2021 Q1	$1.15M	Buy	+300,000	New	+$1.14M	0.39%	45

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Affinity Asset Advisors's BLU Position: Q2 2023 in Review

Affinity Asset Advisors sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 881,329 shares — an estimated $6.35M sold.

Affinity Asset Advisors first reported a position in BLU in Q1 2021 and held it in 9 quarters. The position peaked at $6.35M in Q1 2023. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Affinity Asset Advisors reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Affinity Asset Advisors sold 881,329 BELLUS Health Inc. shares in Q2 2023, an estimated $6.35M.
Affinity Asset Advisors first reported a position in BELLUS Health Inc. in Q1 2021 and held it in 9 quarters.
Affinity Asset Advisors's BELLUS Health Inc. position peaked at $6.35M in Q1 2023.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Affinity Asset Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.